Previous Article | Next Article 
Applied and Environmental Microbiology, August 2001, p. 3763-3766, Vol. 67, No. 8
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.8.3763-3766.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antibiotic Resistance in Salmonella enterica Serovar
Typhimurium Exposed to Microcin-Producing Escherichia
coli
Steve A.
Carlson,1,*
Timothy S.
Frana,2 and
Ronald W.
Griffith2
Preharvest Food Safety and Enteric Disease
Research Unit, National Animal Disease Center, U.S. Department of
Agriculture Agricultural Research Service, Ames, Iowa
50010,1 and Department of Veterinary
Microbiology and Preventive Medicine, Iowa State University College
of Veterinary Medicine, Ames, Iowa 500112
Received 26 March 2001/Accepted 23 May 2001
 |
ABSTRACT |
Microcin 24 is an antimicrobial peptide secreted by uropathogenic
Escherichia coli. Secretion of microcin 24 provides an
antibacterial defense mechanism for E. coli. In a
plasmid-based system using transformed Salmonella
enterica, we found that resistance to microcin 24 could be seen
in concert with a multiple-antibiotic resistance phenotype. This
multidrug-resistant phenotype appeared when Salmonella was
exposed to an E. coli strain expressing microcin 24. Therefore, it appears that multidrug-resistant Salmonella
can arise as a result of an insult from other pathogenic bacteria.
 |
TEXT |
Microcins are antimicrobial
peptides secreted by bacteria as a means of disabling neighboring
bacteria (1). Microcin 24 (Mcc24) is a colicin secreted by
a strain of uropathogenic Escherichia coli
(18). A previous study demonstrated that Mcc24 has
activity against Salmonella enterica and most E. coli strains but not against Campylobacter or
Listeria strains (18). We also found that
Mcc24 does not have activity against
multiple-antibiotic-resistant Klebsiella pneumoniae (ATCC MCV37) (data not shown). In the present study, we
evaluated the ability of S. enterica serotype Typhimurium to develop resistance to Mcc24 and how the development of Mcc24 resistance related to resistance to antibiotics. This study was undertaken to
determine if the use of Mcc24 in probiotic bacteria, as described previously (23), could lead to antibiotic resistance in
Salmonella.
We pursued the multiple-antibiotic resistance (mar) operon
as a potential component of Mcc24 resistance since this operon regulates resistance to a variety of foreign substances in
Salmonella (7). The mar operon
regulates an efflux system that facilitates the expulsion of
antibiotics and organic solvents (6). The mar
operon is regulated by MarR, a repressor protein that prevents the
transcription of marAB (15). Transcription of
marAB occurs when MarR is absent due to an inhibition of
translation of marR (20), altered as a result
of mutagenesis of marR (20) or sequestration by
salicylate (5). As part of this study we used a
plasmid-based system to attenuate the Mar phenotype in a manner similar
to that of White et al. (22), who used antisense DNA
inhibition to block the expression of marA, a regulator of
an efflux system (16). S. enterica serotype
Typhimurium strain SL1344 (24) was transformed with pBAD,
a high-copy-number plasmid with a pBM1 replicon (Invitrogen) containing
the PCR-derived marR gene. The marR gene was
cloned from SL1344 DNA using PCR conditions described previously
(3) with 5'-ATGAAAAGCACCAGTGATCTGTTC-3' and
5'-CCTACGGCAGATT-TTTCTTGAGCAA-3' as forward and
reverse primers, respectively. The expression of marR in pBAD is under the control of arabinose via the
araBAD promoter (12, 14).
SL1344 was also transformed with another plasmid containing the CFP
(cyan derivative of green fluorescent protein [8]; Clontech) gene cloned into pCRII Blunt, a high-copy-number plasmid with
a pBMI replicon and the Lac promoter for transcription of the cloned
gene (Invitrogen), as previously described (10). This plasmid was included to visually distinguish S. enterica serotype Typhimurium from an Mcc24-producing
E. coli strain (ampicillin-resistant strain
MC4100pGOB18 [23]). SL1344 cotransformants,
designated SL1344/CFP/marR, were propagated in Lennox L
broth (GIBCO-BRL) containing 100 µg of ampicillin per ml and 64 µg
of kanamycin per ml. Ampicillin resistance is conferred by a
beta-lactamase encoded by pBAD, while kanamycin resistance is conferred
by a phosphotransferase encoded by pCRII Blunt.
To evaluate Mcc24 resistance in S. enterica serotype
Typhimurium in a system that mimics the in vivo commingling of
Salmonella and E. coli, we flooded
SL1344/CFP/marR (approximately 2 × 108 bacteria) on Lennox L agar. Next we soaked a filter
disk (Bacto concentration disks, sterile blanks; Difco) in Lennox L
broth containing Mcc24-producing E. coli MC4100pGOB18
(109 organisms/ml) and placed this disk in the middle of
the SL1344/CFP/marR-laden agar plate. Bacteria were then
grown together on Lennox L agar plates containing ampicillin at 37°C overnight.
As shown in Fig. 1, a zone of inhibition
was observed around the disk soaked in E. coli strain
MC4100pGOB18. Table 1 reveals that this
zone was due to a secreted protein since the inhibition was present if
trichloroacetic acid (TCA)-precipitated supernatants from E. coli strain MC4100pGOB18 were used instead of broth containing the
bacteria. The zone also disappeared for SL1344 transformed with pCRXL,
a high-copy-number plasmid with a ColE1 replicon, the Lac promoter
for transcription of the cloned gene (Invitrogen), and the
Mcc24 immunity gene (mtfl; GenBank accession number
U47048). The mtfl gene was amplified by PCR from the pGOB18
plasmid. Additionally, the zone of inhibition disappeared if
TCA-precipitated supernatants from E. coli strain
MC4100pGOB18 were treated with 1 mg of pronase E (Sigma) per ml. As
shown in Fig. 2, the zone was also absent if SL1344/CFP/marR or SL1344 was grown in Lennox L broth and
incubated on Lennox L agar, both containing 3.5 mM salicylate (Sigma).
Salicylate can activate the Mar phenotype by physically binding to MarR
(5), thus competitively eliminating the repressor effect
of MarR on the mar operon (15). Therefore, it
appears that resistance to Mcc24 can occur through the mar
response. This is also apparent since the zone was absent for S. enterica serotype Typhimurium strain 8431 (Table 1), a mutant
exhibiting a Mar-like phenotype (4). Additionally, the
salicylate-mediated induction of Mcc24 resistance was prevented by
0.2%-arabinose-induced episomal expression of MarR from pBAD. That is,
repression of marA transcription occurred as a result of
competitive antagonism of salicylate-mediated derepression by
episomally derived MarR. Chromosomal and episomal marR DNA sequences were not changed by the salicylate or arabinose treatment. Sequencing was performed using pBAD-specific primers for episomal marR, open reading frame 221, and marA flanking
sequences for chromosomal marR (GenBank accession number
U54468; data not shown).

View larger version (189K):
[in this window]
[in a new window]
|
FIG. 1.
Mcc24-mediated zone of inhibition of
SL1344/CFP/marR. SL1344/CFP/marR and E. coli strain MC4100pGOB18 (center of plate) were incubated together
as described in the text.
|
|

View larger version (150K):
[in this window]
[in a new window]
|
FIG. 2.
Induction of the Mar phenotype in
SL1344/CFP/marR. SL1344/CFP/marR and E. coli strain MC4100pGOB18 (center of plate) were incubated together
in the presence of 3.5 mM salicylate.
|
|
To evaluate the potential relationship between resistance to Mcc24 and
multiple-antibiotic resistance, we determined the MICs of
ciprofloxacin, chloramphenicol, tetracycline, and rifampin. These four
antibiotics were chosen since they represent part of the Mar phenotype
(6). MICs were determined by inoculating 106
bacteria into 1-ml aliquots of Mueller-Hinton broth (Difco)
containing serial dilutions of antibiotics per NCCLS
guidelines. Bacteria were grown aerobically, and MICs were ascribed
based on the lowest concentration of antibiotic that inhibited growth.
Table 1 reveals that salicylate-mediated Mcc24 resistance occurred in
concert with an increase in ciprofloxacin MICs. Additionally,
SL1344/CFP/marR exhibited increases in the MICs of
chloramphenicol, tetracycline, and rifampin. Simultaneous exposure to
arabinose prevented the salicylate-mediated change in ciprofloxacin MICs.
To evaluate the mar response in relationship to Mcc24
resistance in Salmonella, we repeatedly selected
SL1344/CFP/marR colonies that bordered the zone of
inhibition (Table 2).
Salmonella colonies were expanded by vigorous shaking for 4 to 6 h at 37°C in Lennox L broth containing ampicillin and
kanamycin. Broth cultures (approximately 2 × 108
bacteria) were then replated with the disk soaked in E. coli strain MC4100pGOB18 on Lennox L agar containing ampicillin. The zone
disappeared after 9, 11, or 18 expansions and replatings in three
separate experiments. As a control, SL1344/CFP/marR colonies from the edge of the plate were also expanded and replated.
SL1344/CFP/marR colonies from the edge of the plate remained
sensitive to Mcc24. We have been unable to isolate Mcc24-resistant
SL1344/CFP/marR colonies from the edge of the plate. In a
representative experiment in which 18 expansion-replating
procedures were required to induce Mcc24 resistance, we found
that resistance to Mcc24 and increased MICs of ciprofloxacin,
tetracycline, chloramphenicol, and rifampin could be prevented by
episomal expression of MarR. Mcc24-sensitive microbes
became Mcc24 resistant, however, after removal of the arabinose. Chromosomal and episomal marR DNA sequences were
not changed by the expansion processes or by the salicylate or
arabinose treatment. Thus, Mcc24 exposure-mediated resistance was
apparently due to activation of the mar system. While a
previous study suggests that resistance to microcin MccB17 can be due
to an export of the peptide in E. coli (11),
this is the first study to document mar-mediated resistance
to a microcin.
Although the mechanism of action for Mcc24 is currently unknown, other
microcins provide antimicrobial action by inhibiting DNA gyrase, by
inhibiting protein expression (17, 21), or by forming
pores in target bacteria (9). Since marR DNA
sequences were not altered and since ancillary MarR may
prevent derepression, it is feasible that Mcc24 can inhibit
translation. The Mcc24-mediated inhibition of translation may decrease
MarR levels below a threshold that normally maintains repression of
mar. Derepression then ensues when this threshold is
breached. That is, Mcc24 indirectly mediates resistance to itself.
In this study, we found that Salmonella can develop
resistance to an E. coli-derived microcin. Extrapolation of
our results indicates that exposure of Salmonella to
Mcc24 can result in multidrug-resistant Salmonella.
Therefore, the ongoing problem with multidrug-resistant Salmonella may be due to the activation of innate pathways
and the acquisition of genetic determinants of antibiotic resistance such as integrons (2, 13, 19). Since ciprofloxacin
resistance in Salmonella is uncommon, the events described
in this study are probably a rare situation in vivo. Nonetheless, it
unfortunately appears that microcin production gives an advantage to
pathogenic E. coli while also potentially selecting for
multidrug-resistant Salmonella.
 |
ACKNOWLEDGMENTS |
We thank Ruth Willson for technical assistance, Sandy Johnson for
secretarial assistance, Chuck Greiner for photography, and Kristi
Anderson, Kim Brogden, and Bonita Glatz for reviewing the manuscript.
S.A.C. and T.S.F. contributed equally to this work.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: USDA-ARS,
National Animal Disease Center, 2300 Dayton Rd., Box 70, Ames, IA
50010. Phone: (515) 663-7612. Fax: (515) 663-7373. E-mail:
scarlson{at}nadc.ars.usda.gov.
 |
REFERENCES |
| 1.
|
Baquero, F.,
D. Bouanchaud,
M. Martinez-Perez, and C. Fernandez.
1978.
Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli.
J. Bacteriol.
135:342-347[Abstract/Free Full Text].
|
| 2.
|
Briggs, C. E., and P. M. Fratamico.
1999.
Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104.
Antimicrob. Agents Chemother.
43:846-849[Abstract/Free Full Text].
|
| 3.
|
Carlson, S. A.,
M. Browning,
K. Ferris, and B. D. Jones.
2000.
Identification of diminished tissue culture invasiveness among multiple antibiotic resistant Salmonella typhimurium DT104.
Microb. Pathog.
28:37-44[CrossRef][Medline].
|
| 4.
|
Carlson, S. A., and K. E. Ferris.
2000.
Augmentation of antibiotic resistance in multiple antibiotic resistant Salmonella typhimurium DT104 following exposure to penicillin derivatives.
Vet. Microbiol.
73:25-35[CrossRef][Medline].
|
| 5.
|
Cohen, S. P.,
H. Hachler, and S. B. Levy.
1993.
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.
J. Bacteriol.
175:1484-1492[Abstract/Free Full Text].
|
| 6.
|
Cohen, S. P.,
L. M. McMurry,
D. C. Hooper,
J. S. Wolfson, and S. B. Levy.
1989.
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Antimicrob. Agents Chemother.
33:1318-1325[Abstract/Free Full Text].
|
| 7.
|
Cohen, S. P.,
W. Yan, and S. B. Levy.
1993.
A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria.
J. Infect. Dis.
168:484-488[Medline].
|
| 8.
|
Cormack, B.,
R. Valdivia, and S. Falkow.
1996.
FACS-optimized mutants of the green fluorescent protein (GFP).
Gene
173:33-38[CrossRef][Medline].
|
| 9.
|
de Lorenzo, V., and A. Pugsley.
1985.
Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane.
Antimicrob. Agents Chemother.
27:666-669[Abstract/Free Full Text].
|
| 10.
|
Frana, T. S., and S. A. Carlson.
2001.
Development and use of a plasmid encoding green fluorescence protein in multiple antibiotic resistant Salmonella.
BioTechniques
30:28-32[Medline].
|
| 11.
|
Garrido, M.,
M. Herrero,
R. Kolter, and F. Moreno.
1988.
The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell.
EMBO J.
7:1853-1862[Medline].
|
| 12.
|
Guzman, L.-M.,
D. Belin,
M. J. Carson, and J. Beckwith.
1995.
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter.
J. Bacteriol.
177:4121-4130[Abstract/Free Full Text].
|
| 13.
|
Hall, R. M., and H. W. Stokes.
1993.
Integrons: novel DNA elements which capture genes by site-specific recombination.
Genetica
90:115-132[CrossRef][Medline].
|
| 14.
|
Lee, N.,
C. Francklyn, and E. P. Hamilton.
1987.
Arabinose-induced binding of AraC protein to araI2 activates the araBAD operon promoter.
Proc. Natl. Acad. Sci. USA
81:8814-8818.
|
| 15.
|
Martin, R. G., and J. L. Rosner.
1995.
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.
Proc. Natl. Acad. Sci. USA
92:5456-5460[Abstract/Free Full Text].
|
| 16.
|
McDermott, P. F.,
D. G. White,
I. Podglajen,
M. N. Alekshun, and S. B. Levy.
1998.
Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis.
J. Bacteriol.
180:2995-2998[Abstract/Free Full Text].
|
| 17.
|
Moreno, F.,
J. L. San Millan,
C. Hernandez-Chico, and R. Kolter.
1995.
Genetics and biochemistry of antibiotic production.
Butterworth-Heimann, Boston, Mass.
|
| 18.
|
O'Brien, G., and H. Mahanty.
1994.
Colicin 24, a new plasmid-borne colicin from a uropathogenic strain of Escherichia coli.
Plasmid
31:288-296[CrossRef][Medline].
|
| 19.
|
Ridley, A., and E. J. Threlfall.
1998.
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104.
Microb. Drug Resist.
4:113-118[Medline].
|
| 20.
|
Sulavik, M. C.,
M. Dazer, and P. F. Miller.
1997.
The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence.
J. Bacteriol.
179:1857-1866[Abstract/Free Full Text].
|
| 21.
|
Vizan, J.,
C. Hernandez-Chico,
I. del Castillo, and F. Moreno.
1991.
The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase.
EMBO J.
10:467-476[Medline].
|
| 22.
|
White, D. G.,
K. Maneewannakul,
E. von Hofe,
M. Zillman,
W. Eisenberg,
A. K. Field, and S. B. Levy.
1997.
Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs.
Antimicrob. Agents Chemother.
41:2699-2704[Abstract].
|
| 23.
|
Wooley, R.,
P. Gibbs, and E. J. Shotts.
1999.
Inhibition of Salmonella typhimurium in the chicken intestinal tract by a transformed avirulent avian Escherichia coli.
Avian Dis.
432:45-50.
|
| 24.
|
Wray, C., and W. J. Sojka.
1978.
Experimental Salmonella typhimurium in calves.
Res. Vet. Sci.
25:139-143[Medline].
|
Applied and Environmental Microbiology, August 2001, p. 3763-3766, Vol. 67, No. 8
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.8.3763-3766.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pleydell, E. J., Brown, P. E., Woodward, M. J., Davies, R. H., French, N. P.
(2007). Sources of Variation in the Ampicillin-Resistant Escherichia coli Concentration in the Feces of Organic Broiler Chickens. Appl. Environ. Microbiol.
73: 203-210
[Abstract]
[Full Text]
-
Lievin-Le Moal, V., Servin, A. L.
(2006). The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota. Clin. Microbiol. Rev.
19: 315-337
[Abstract]
[Full Text]